Atlas FDA

VITROS Anti-HBs

FDA premarket approval P000014/S035 · decided 2019-06-19

Approval details

PMA number
P000014
Supplement
S035
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
VITROS Anti-HBs
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Ortho-Clinical Diagnostics, Inc.
Date received
2019-05-21
Decision date
2019-06-19
Days to decision
29 days
Decision code
OK30
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Rochester, NY
Statement
Establishment of a new Environmental Controlled Area Room at an existing facility.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VITROS Immunodiagnostic Products hs Troponin I Reagent Pack (K252393)Ortho-Clinical Diagnostics, Inc.2025-10-29
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack, VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Calibrators (DEN210040)Ortho-Clinical Diagnostics, Inc.2023-05-05
VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack, VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Calibrator (DEN210038)Ortho-Clinical Diagnostics, Inc.2023-05-05
VITROS Chemistry Products PHBR Slides (K210858)Ortho-Clinical Diagnostics, Inc.2021-08-13
VITROS XT Chemistry Products ALB-TP Slides (K191316)Ortho-Clinical Diagnostics, Inc.2019-06-07
VITROS XT Chemistry Products TBIL-ALKP Slides (K190807)Ortho-Clinical Diagnostics, Inc.2019-04-26
VITROS XT Chemistry Products GLU-Ca Slides (K190520)Ortho-Clinical Diagnostics, Inc.2019-04-03
VITROS XT Chemistry Products TRIG-CHOL Slides (K190490)Ortho-Clinical Diagnostics, Inc.2019-03-27